Global Orthopaedic Oncology 麻豆原创 2024 by Company, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102428419

Publication Date:

November 20, 2024

Pages:

108

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Orthopaedic Oncology market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Orthopaedic oncology听is a new sub-speciality of orthopaedics which deals with the detection, treatment and follow-up of bone and soft tissue tumours.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
The publisher report includes an overview of the development of the Orthopaedic Oncology industry chain, the market status of Hospitals (Surgery, Chemotherapy), Research Laboratories (Surgery, Chemotherapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Orthopaedic Oncology.
Regionally, the report analyzes the Orthopaedic Oncology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Orthopaedic Oncology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Orthopaedic Oncology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Orthopaedic Oncology industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Surgery, Chemotherapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Orthopaedic Oncology market.
Regional Analysis: The report involves examining the Orthopaedic Oncology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Orthopaedic Oncology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Orthopaedic Oncology:
Company Analysis: Report covers individual Orthopaedic Oncology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Orthopaedic Oncology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Hospitals, Research Laboratories).
Technology Analysis: Report covers specific technologies relevant to Orthopaedic Oncology. It assesses the current state, advancements, and potential future developments in Orthopaedic Oncology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Orthopaedic Oncology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Orthopaedic Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
麻豆原创 segment by Type
Surgery
Chemotherapy
Radiation Therapy
Targeted Therapy
麻豆原创 segment by Application
Hospitals
Research Laboratories
麻豆原创 segment by players, this report covers
Stryker Corporation
Amgen Inc.
Tyco Electronics UK Holdings Ltd.
Accentus Inc.
Canon Medical Systems
Siemens Healthineers
MD Anderson Cancer Center
Roche
Novartis AG
Sanofi S.A.
麻豆原创 segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Orthopaedic Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Orthopaedic Oncology, with revenue, gross margin and global market share of Orthopaedic Oncology from 2019 to 2024.
Chapter 3, the Orthopaedic Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Orthopaedic Oncology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Orthopaedic Oncology.
Chapter 13, to describe Orthopaedic Oncology research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Orthopaedic Oncology
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 Classification of Orthopaedic Oncology by Type
1.3.1 Overview: Global Orthopaedic Oncology 麻豆原创 Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Orthopaedic Oncology Consumption Value 麻豆原创 Share by Type in 2023
1.3.3 Surgery
1.3.4 Chemotherapy
1.3.5 Radiation Therapy
1.3.6 Targeted Therapy
1.4 Global Orthopaedic Oncology 麻豆原创 by Application
1.4.1 Overview: Global Orthopaedic Oncology 麻豆原创 Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Hospitals
1.4.3 Research Laboratories
1.5 Global Orthopaedic Oncology 麻豆原创 Size & Forecast
1.6 Global Orthopaedic Oncology 麻豆原创 Size and Forecast by Region
1.6.1 Global Orthopaedic Oncology 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Orthopaedic Oncology 麻豆原创 Size by Region, (2019-2030)
1.6.3 North America Orthopaedic Oncology 麻豆原创 Size and Prospect (2019-2030)
1.6.4 Europe Orthopaedic Oncology 麻豆原创 Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Orthopaedic Oncology 麻豆原创 Size and Prospect (2019-2030)
1.6.6 South America Orthopaedic Oncology 麻豆原创 Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Orthopaedic Oncology 麻豆原创 Size and Prospect (2019-2030)
2 Company Profiles
2.1 Stryker Corporation
2.1.1 Stryker Corporation Details
2.1.2 Stryker Corporation Major Business
2.1.3 Stryker Corporation Orthopaedic Oncology Product and Solutions
2.1.4 Stryker Corporation Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Stryker Corporation Recent Developments and Future Plans
2.2 Amgen Inc.
2.2.1 Amgen Inc. Details
2.2.2 Amgen Inc. Major Business
2.2.3 Amgen Inc. Orthopaedic Oncology Product and Solutions
2.2.4 Amgen Inc. Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Amgen Inc. Recent Developments and Future Plans
2.3 Tyco Electronics UK Holdings Ltd.
2.3.1 Tyco Electronics UK Holdings Ltd. Details
2.3.2 Tyco Electronics UK Holdings Ltd. Major Business
2.3.3 Tyco Electronics UK Holdings Ltd. Orthopaedic Oncology Product and Solutions
2.3.4 Tyco Electronics UK Holdings Ltd. Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Tyco Electronics UK Holdings Ltd. Recent Developments and Future Plans
2.4 Accentus Inc.
2.4.1 Accentus Inc. Details
2.4.2 Accentus Inc. Major Business
2.4.3 Accentus Inc. Orthopaedic Oncology Product and Solutions
2.4.4 Accentus Inc. Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Accentus Inc. Recent Developments and Future Plans
2.5 Canon Medical Systems
2.5.1 Canon Medical Systems Details
2.5.2 Canon Medical Systems Major Business
2.5.3 Canon Medical Systems Orthopaedic Oncology Product and Solutions
2.5.4 Canon Medical Systems Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Canon Medical Systems Recent Developments and Future Plans
2.6 Siemens Healthineers
2.6.1 Siemens Healthineers Details
2.6.2 Siemens Healthineers Major Business
2.6.3 Siemens Healthineers Orthopaedic Oncology Product and Solutions
2.6.4 Siemens Healthineers Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Siemens Healthineers Recent Developments and Future Plans
2.7 MD Anderson Cancer Center
2.7.1 MD Anderson Cancer Center Details
2.7.2 MD Anderson Cancer Center Major Business
2.7.3 MD Anderson Cancer Center Orthopaedic Oncology Product and Solutions
2.7.4 MD Anderson Cancer Center Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 MD Anderson Cancer Center Recent Developments and Future Plans
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Orthopaedic Oncology Product and Solutions
2.8.4 Roche Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.8.5 Roche Recent Developments and Future Plans
2.9 Novartis AG
2.9.1 Novartis AG Details
2.9.2 Novartis AG Major Business
2.9.3 Novartis AG Orthopaedic Oncology Product and Solutions
2.9.4 Novartis AG Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.9.5 Novartis AG Recent Developments and Future Plans
2.10 Sanofi S.A.
2.10.1 Sanofi S.A. Details
2.10.2 Sanofi S.A. Major Business
2.10.3 Sanofi S.A. Orthopaedic Oncology Product and Solutions
2.10.4 Sanofi S.A. Orthopaedic Oncology Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.10.5 Sanofi S.A. Recent Developments and Future Plans
3 麻豆原创 Competition, by Players
3.1 Global Orthopaedic Oncology Revenue and Share by Players (2019-2024)
3.2 麻豆原创 Share Analysis (2023)
3.2.1 麻豆原创 Share of Orthopaedic Oncology by Company Revenue
3.2.2 Top 3 Orthopaedic Oncology Players 麻豆原创 Share in 2023
3.2.3 Top 6 Orthopaedic Oncology Players 麻豆原创 Share in 2023
3.3 Orthopaedic Oncology 麻豆原创: Overall Company Footprint Analysis
3.3.1 Orthopaedic Oncology 麻豆原创: Region Footprint
3.3.2 Orthopaedic Oncology 麻豆原创: Company Product Type Footprint
3.3.3 Orthopaedic Oncology 麻豆原创: Company Product Application Footprint
3.4 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 麻豆原创 Size Segment by Type
4.1 Global Orthopaedic Oncology Consumption Value and 麻豆原创 Share by Type (2019-2024)
4.2 Global Orthopaedic Oncology 麻豆原创 Forecast by Type (2025-2030)
5 麻豆原创 Size Segment by Application
5.1 Global Orthopaedic Oncology Consumption Value 麻豆原创 Share by Application (2019-2024)
5.2 Global Orthopaedic Oncology 麻豆原创 Forecast by Application (2025-2030)
6 North America
6.1 North America Orthopaedic Oncology Consumption Value by Type (2019-2030)
6.2 North America Orthopaedic Oncology Consumption Value by Application (2019-2030)
6.3 North America Orthopaedic Oncology 麻豆原创 Size by Country
6.3.1 North America Orthopaedic Oncology Consumption Value by Country (2019-2030)
6.3.2 United States Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
6.3.3 Canada Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
6.3.4 Mexico Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
7 Europe
7.1 Europe Orthopaedic Oncology Consumption Value by Type (2019-2030)
7.2 Europe Orthopaedic Oncology Consumption Value by Application (2019-2030)
7.3 Europe Orthopaedic Oncology 麻豆原创 Size by Country
7.3.1 Europe Orthopaedic Oncology Consumption Value by Country (2019-2030)
7.3.2 Germany Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
7.3.3 France Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
7.3.4 United Kingdom Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Russia Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
7.3.6 Italy Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Orthopaedic Oncology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Orthopaedic Oncology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Orthopaedic Oncology 麻豆原创 Size by Region
8.3.1 Asia-Pacific Orthopaedic Oncology Consumption Value by Region (2019-2030)
8.3.2 China Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
8.3.3 Japan Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
8.3.4 South Korea Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
8.3.5 India Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Southeast Asia Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Australia Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
9 South America
9.1 South America Orthopaedic Oncology Consumption Value by Type (2019-2030)
9.2 South America Orthopaedic Oncology Consumption Value by Application (2019-2030)
9.3 South America Orthopaedic Oncology 麻豆原创 Size by Country
9.3.1 South America Orthopaedic Oncology Consumption Value by Country (2019-2030)
9.3.2 Brazil Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
9.3.3 Argentina Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Orthopaedic Oncology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Orthopaedic Oncology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Orthopaedic Oncology 麻豆原创 Size by Country
10.3.1 Middle East & Africa Orthopaedic Oncology Consumption Value by Country (2019-2030)
10.3.2 Turkey Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
10.3.4 UAE Orthopaedic Oncology 麻豆原创 Size and Forecast (2019-2030)
11 麻豆原创 Dynamics
11.1 Orthopaedic Oncology 麻豆原创 Drivers
11.2 Orthopaedic Oncology 麻豆原创 Restraints
11.3 Orthopaedic Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Orthopaedic Oncology Industry Chain
12.2 Orthopaedic Oncology Upstream Analysis
12.3 Orthopaedic Oncology Midstream Analysis
12.4 Orthopaedic Oncology Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Companies Mentioned:

Stryker Corporation
Amgen Inc.
Tyco Electronics UK Holdings Ltd.
Accentus Inc.
Canon Medical Systems
Siemens Healthineers
MD Anderson Cancer Center
Roche
Novartis AG
Sanofi S.A.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.